Jennifer Doudna, Ph.D. is an American biochemist best known for her discovery with French microbiologist, Emmanuelle Charpentier, Ph.D., of a molecular tool known as clustered regularly interspaced short palindromic repeats CRISPR-Cas9. The discovery of CRISPR-Cas9, made in 2012, provided the foundation for gene editing, enabling researchers to make specific changes to DNA sequences in a way that was far more efficient and technically simpler than earlier methods.
In addition to the 2020 Nobel Prize, Doudna has received numerous other awards for her research, including the Gruber Prize in Genetics (2015) and the Canada Gairdner International Award (2016), both shared with Charpentier. Doudna is a Co-Founder of the Innovative Genomics Institute as well as multiple biotechnology companies, most recently Scribe Therapeutics and Mammoth Biosciences.
Six ARCS Scholar Speakers will present their work in fields ranging from robotics to climate change. Upon registering with the Symposium, scholars were asked to self-nominate for presentation during the general session. The ARCS Scholar Relations Committee then selected one student from each of ARCS Northern California's six partner universities, representing a broad cross-section of the research exhibited throughout the Symposium. Our six Presenting Scholars are:
Jan Mikhale Cajulao
Following the main program, these scholars will participate in a Q&A session moderated by Jeremy Reiter, M.D., Ph.D., Professor and Chair of Biophysics and Biochemistry at UCSF, and Science Advisor, ARCS Foundation, Northern California Chapter.